Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,049 shares at $898.00 ($1.8M) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |
| REGN | SELL | 2023-01-30 | $747 | — | Filing → |